Relating to the use of glucagon medication on certain public and private school campuses.
Relating to the administration of opioid antagonists by a school nurse at public school campuses.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.
Relating to the administration of opioid antagonists by a school nurse or school district administrative personnel at public school campuses.
Relating to the use of prescription glucagon medication on public and private school campuses.
Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
Relating to a policy adopted by school districts allowing parent volunteers on school district campuses.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the establishment of a grant program for school districts or open-enrollment charter school campuses that are designated as full-service community schools.